Company patents
Advanced Neuromodulation Systems, Inc.
Advanced Neuromodulation Systems, Inc. surprisingly shows a significant and sustained decline in its core 'Electrotherapy / Radiation Therapy' category, which still represents 87.3% of its portfolio, with a -19.3% YoY drop in 2025 and a -58.7% decline so far in 2026. This shift is contrasted by an emerging focus on 'Computer Security', which saw a remarkable +175.0% YoY growth in 2025, indicating a strategic pivot towards digital and data protection within its medical device ecosystem.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
212 US filings (since 2023) · 12 categories · 5 themes
Systems that provide therapeutic stimulation or field therapy through wearable devices, often incorporating physiological sensing and closed-loop feedback for personalized and adaptive treatment.
Therapeutic application of electrical signals to nerves or tissues to modulate their activity, often using implantable devices, electrodes, and sophisticated programming for various conditions.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Digital platforms and systems that deliver tailored therapeutic interventions, guidance, or recommendations to patients based on their individual health data, biometric feedback, and computational models (e.g., AI/ML, physiological simulations).
Patents
Showing 1-10 of 314